Abstract:Background Chronic kidney disease (CKD) patients sustain a fairly high prevalence of cardiovascular disease (CVD). Microvascular inflammation is an early manifestation of CVD, and the released mitochondrial DNA (MtDNA) has been proposed to be a crucial integrator of inflammatory signals. Herein, the aim of this study was to determine the relationship between CVD, microvessel, and circulating MtDNA in the settings of uremia. Methods Forty-two maintenance hemodialysis (MHD) patients and 36 health controls were enrolled in this study. Plasma cell-free MtDNA was detected by TaqMan-based qPCR assay. CVD risk markers including high-sensitive C-reactive protein (Hs-CRP), monocyte chemoattractant protein-1 (MCP-1), fibrinogen, and erythrocyte sedimentation rate (ESR) were measured by standard assays. Ten-year CVD risk was calculated from the Framingham risk score (FRS) model. In vitro study, human cardiac microvascular endothelial cells (HCMECs) were incubated with normal or uremic serum, with or without exogenous MtDNA. Intracellular toll-like receptor 9 (TLR9), adhesion molecule 1 (ICAM-1), MCP-1 and tumor necrosis factor-α (TNF-α) and cytosolic MtDNA were detected by qPCR. Results Plasma MtDNA in MHD patients was significantly higher than healthy controls (4.74 vs. 2.41 × 10 5 copies/mL; p = 0.000). Subsequently, the MHD patients were classified into two groups based on the MtDNA median (4.34 × 10 5 copies/mL). In stratified analyses, the levels of Hs-CRP (5.02 vs. 3.73 mg/L; p = 0.042) and MCP-l (99.97 vs. 64.72 pg/mL; p = 0.008) and FRS (21.80 vs. 16.52; p = 0.016) in the high plasma MtDNA group were higher than those in the low plasma MtDNA group. In vitro study, we found that exogenous MtDNA aggravated uremic serum-induced microvascular inflammation (ICAM-1 and TNF-α) in HCMECs (all p < 0.05). Besides, the addition of MtDNA to the medium resulted in a further increase in cytosolic MtDNA and TLR9 levels in uremic serum-treated cells (all p < 0.05). In patients with MHD, MtDNA levels in plasma were significantly reduced after a single routine hemodialysis (pre 4.47 vs. post 3.45 × 10 5 copies/mL; p = 0.001) or hemodiafiltration (pre 4.85 vs. post 4.09 × 10 5 copies/mL; p = 0.001). These two approaches seem similar in terms of MtDNA clearance rate (21.26% vs. 11.94%; p = 0.172). Conclusions Overall, the present study suggests that MtDNA released into the circulation under the uremic toxin environment may adversely affect the cardiovascular system by exacerbating microvascular inflammation, and that reducing circulating MtDNA might be a future therapeutic strategy for the prevention of MHD-related CVD.

NF-κB activity of peripheral blood mononuclear cell,microinflammation,oxidative stress and cardiovascular disease in hemodialysis patients

The Relationship Between NF-κB Activity of Peripheral Blood Mononuclear Cell and Cardiovascular Disease(cvd) in Patients of Maintenance Hemodialysis(mhd)

Interferon lambda modulates proinflammatory cytokines production in PBMCs from patients with chronic kidney disease

Association of Serum L-kynurenine with Nutritional Status and Vascular Stiffness in Maintenance Hemodialysis Patients

The correlation between nuclear factor kappa B expressed in peripheral blood mononuclear cells and the characteristics of coronary atherosclerosis plaque in patients with acute coronary syndrome

Nuclear NF-κB p65 in Peripheral Blood Mononuclear Cells Correlates with Urinary MCP-1, RANTES and the Severity of Type 2 Diabetic Nephropathy

Increased Level of Free-Circulating MtDNA in Maintenance Hemodialysis Patients: Possible Role in Systemic Inflammation.

Decreased lymphocyte and increased monocyte count in peripheral blood is associated with cardiovascular disease and one-year mortality in maintenance hemodialysis patients

Multivariate analysis of oxidative stress in maintenance hemodialysis patients

Measurement and clinical significance of the activity of nuclear factor κB in peripheral blood mononuclear cells in the patients with acute coronary syndrome

Relationship of Serum Amino-Terminal Pro-B-natriuretic Peptide with Cardiovascular Disease and Malnutrition in Patients with Maintenance Hemodialysis

The Effects of Oral Vitamin Con Microinflammatory State in Hemodialysis Patients

Cross-sectional Study of NT-pro Brain Natriuretic Peptide and Its Correlation with Heart Remodeling and Function in Maintenance Hemodialysis Patients

Association of circulating MtDNA with CVD in hemodialysis patients: involvement of MtDNA-induced cardiac microvascular inflammation

Inflammatory index is a promising biomarker for maintenance hemodialysis patients with cardiovascular disease

Altered monocytic phenotypes are linked with systemic inflammation and may be linked to mortality in dialysis patients

Serum hepcidin is associated with iron status and micro-inflammation in hemodialysis patients

Markers of oxidative stress in patients undergoing maintenance hemodialysis:establishment and evaluation

Association of circulating MtDNA with CVD in hemodialysis patients and in vitro effect of exogenous MtDNA on cardiac microvascular inflammation

Assessment of serum cardiac troponin T and C-reactive protein in predicting hemodialysis outcome

The change of nuclear factor κB activity in peripheral blood monocytes in patients with acute coronary syndrome